EMA publishes agenda for 22-25 February CHMP meeting


22 February 2021 - The EMA has published a draft agenda for this week's CHMP meeting.

The CHMP is due to issue opinions for the following technologies:

  • Abiraterone acetate
  • Berotralstat
  • Bevacizumab
  • Dasatinib monohydrate
  • Dostarlimab

Read CHMP agenda

Michael Wonder

Posted by:

Michael Wonder